Incidence of Multidrug-Resistant UTI

Authors

  • Maryam Abbasi Pediatrics Department, Sheikh Khalifa Bin Zayed Al Nahyan/Combined Military Hospital, Muzaffarabad, Azad Jammu and Kashmir, Pakistan.
  • Khawaja Tahir Aziz Pediatrics Department, Azad Jammu and Kashmir Medical College, Muzaffarabad/Sheikh Khalifa Bin Zayed Al Nahyan/Combined Military Hospital, Muzaffarabad.
  • Amna Abbasi Department of Obs and Gynae, Sheikh Khalifa Bin Zayed Al Nahyan/Combined Military Hospital, Muzaffarabad, Azad Jammu and Kashmir, Pakistan.

DOI:

https://doi.org/10.70749/ijbr.v3i3.950

Keywords:

Urinary Tract Infection, MDR, E. Coli, Antimicrobial Resistance

Abstract

Background: Children are experiencing more difficult-to-manage UTIs as a result of the worldwide rise of multidrug-resistant pathogens. Methodology: It was a cross-sectional observational study. The study was conducted at Sheikh Khalifa Bin Zayed Al Nahyan/Combined Military Hospital, Muzaffarabad, Azad Jammu and Kashmir, Pakistan. 215 patients were included in the study. A standardized data collection questionnaire was used to collect data on biosociodemographics such as age, gender, and history of UTIs. Data analysis was done using IBM SPSS version 25. Chi-square was applied to find the association between MDR UTI and other variables such as the presence of UTI, antibiotic use, hospitalization requirement, as well as recurrent UTI. Multivariate logistic regression was applied to evaluate independent risk factors for MDR-UTI, which was expressed as adjusted Odds Ratios with 95% CI. Results: In this investigation on the epidemiology of multidrug-resistant UTI in children aged one to fifteen years, 53 percent were female, and 47 percent of cases were male, and all 104 multiple drug-resistant UTI cases fell into this category, indicating a significant correlation (p=0.00). Multiple drug-resistant UTI was substantially related to hospitalisation, since all 80 hospitalised patients had the condition (p-value = 0.00). gender (p-value = 0.767) was not a significant predictor of multiple drug-resistant urinary tract infection, and the unreliable model coefficients indicate potential data limitations. Conclusion: The study found a substantial link between multiple drug-resistant UTIs, hospitalization, and UTI presence. All multiple drug-resistant UTI cases were in children with confirmed UTI. through carbapenems were the most used antibiotics, there was no significant relationship between drug type and multiple drug-resistant UTI. These findings underline the importance of effectively preventing and managing multiple drug-resistant UTIs in pediatric patients.

Downloads

Download data is not yet available.

References

Mortazavi-Tabatabaei SAR, Ghaderkhani J, Nazari A, Sayehmiri K, Sayehmiri F, Pakzad I. Pattern of Antibacterial Resistance in urinary tract infections: a systematic review and Meta-analysis. Int J Prev Med. 2019;10:169. https://doi.org/10.4103/ijpvm.ijpvm_419_17

Frazee BW, Trivedi T, Montgomery M, Petrovic DF, Yamaji R, Riley L. Emergency Department urinary tract infections caused by extended-spectrum β-Lactamase-producing Enterobacteriaceae: many patients have no identifiable risk factor and discordant empiric therapy is common. Ann Emerg Med. 2018;72(4):449–56. https://doi.org/10.1016/j.annemergmed.2018.05.006

Kaye KS, et al. Antimicrobial resistance trends in urine Escherichia coli isolates from adult and adolescent females in the United States from 2011 to 2019: rrising ESBL strains and impact on patient management. Clin Infect Dis. 2021;73(11):1992–9. https://doi.org/10.1093/cid/ciab560

Ramírez-Castillo FY, Moreno-Flores AC, Avelar-González FJ, Márquez-Díaz F, Harel J, Guerrero-Barrera AL. An evaluation of multidrug-resistant Escherichia coli isolates in urinary tract infections from Aguascalientes, Mexico: cross-sectional study. Ann Clin Microbiol Antimicrob. 2018 Jul 24;17(1):34. https://doi.org/10.1186/s12941-018-0286-5.

Bhatt CP, Shrestha B, Khadka S, Swar S, Shah B, Pun K. Etiology of urinary tract infection and drug resistance cases of uropathogenes. J Kathmandu Med Coll 2012; 1: 114–120. https://doi.org/10.3126/jkmc.v1i2.8150

Dehbanipour R, Rastaghi S, Sedighi M, Maleki N, Faghri J. High prevalence of multidrug resistanceuropathogenic Escherichia coli strains, Isfahan, Iran. J Nat Sci Biol Med 2016; 7: 22–26. https://doi.org/10.4103/0976-9668.175020

Stewardson AJ, Vervoort J, Adriaenssens N, Coenen S, Godycki-Cwirko M, Kowalczyk A, et al. Effect of outpatient antibiotics for urinary tract infections on antimicrobial resistance among commensal Enterobacteriaceae: a multinational prospective cohort study. Clin Microbiol Infect 2018; 24: 972–979 https://doi.org/10.1016/j.cmi.2017.12.026

Teillant A, Gandra S, Barter D, Morgan DJ, Laxminarayan R. Potential burden of antibiotic resistance on surgery and cancer chemotherapy antibiotic prophylaxis in the USA: a literature review and modelling study. Lancet Infect Dis 2015; 15: 1429–1437 https://doi.org/10.1016/s1473-3099(15)00270-4

Ahmed S, Shree N, Narula AS, Nirala PK, Majid H, Garg A, Nayeem U, Khan MA. The prevalence of multidrug resistance in uropathogens of patients admitted in the intensive care unit of a tertiary care hospital. NaunynSchmiedebergs Arch Pharmacol. 2024 Sep;397(9):7117-7127. https://doi.org/10.1007/s00210-024-03202-8.

Alhomayani FK, Alazwari NM, Alshhrani MS, Alkhudaydi AS, Basaba AS, Alharthi TM, Alghamdi MM, Aljuaid AS, Alosimi NM, Alqethami AM. The prevalence of multiple drug resistant urinary tract infections: A single-centered, observational retrospective study in King Abdulaziz Specialized Hospital, Taif, Saudi Arabia. Saudi Med J. 2022 Aug;43(8):927-932. https://doi.org/10.15537/smj.2022.43.8.20220238.

Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015 May;13(5):269-84. https://doi.org/10.1038/nrmicro3432.

Gajdács M, Burián K, Terhes G. Resistance Levels and Epidemiology of Non-Fermenting Gram-Negative Bacteria in Urinary Tract Infections of Inpatients and Outpatients (RENFUTI): A 10-Year Epidemiological Snapshot. Antibiotics (Basel). 2019 Sep 9;8(3):143. https://doi.org/10.3390/antibiotics8030143.

Mahony M, McMullan B, Brown J, Kennedy SE. Multidrug-resistant organisms in urinary tract infections in children. Pediatr Nephrol. 2020 Sep;35(9):1563-1573. https://doi.org/10.1007/s00467-019-04316-5.

Agrawal, Manish Kumar1,2; Baveja, Sujata3,4; Joshi, Anuja1. Pediatric Urinary Tract Infections at a Tertiary Care Center: Microbial Diversity and Antibiotic Resistance Patterns. Indian Journal of Medical Specialities 15(4):p 264-267, Oct–Dec 2024. https://doi.org/10.4103/injms.injms-2524

Fatma Hammami, MakramKoubaa, Amal Chakroun, Khaoula Rekik, Fatma Smaoui, EmnaElleuch, ChakibMarrakchi, Mounir Ben Jemaa, 1697. The Burden Of Multidrug-Resistant Urinary Tract Infections, Open Forum Infectious Diseases, Volume 7, Issue Supplement_1, October 2020, Page S831, https://doi.org/10.1093/ofid/ofaa439.1875

Malcolm W, Fletcher E, Kavanagh K, Deshpande A, Wiuff C, Marwick C, Bennie M. Risk factors for resistance and MDR in community urine isolates: population-level analysis using the NHS Scotland Infection Intelligence Platform. J Antimicrob Chemother. 2018 Jan 1;73(1):223-230. https://doi.org/10.1093/jac/dkx363.

Murray MT, Beauchemin MP, Neu N, Larson EL. Prior antibiotic use and acquisition of multidrug-resistant organisms in hospitalized children: a systematic review. Infection Control & Hospital Epidemiology. 2019 Oct;40(10):1107-15. https://doi.org/10.1017/ice.2019.215

Lahrman FJ, Olsen MA, Stwalley D, Burnham JP, Kwon JH. 1474. Epidemiology and Outcomes of Hospitalized Patients with Urinary Tract Infections (UTI) Due to Multidrug-Resistant Organisms (MDRO). In Open Forum Infectious Diseases 2019 Oct 23 (Vol. 6, No. Suppl 2, p. S537). https://doi.org/10.1093/ofid/ofz360.1338

Benaissa E, Belouad E, Mechal Y, Benlahlou Y, Chadli M, Maleb A, Elouennass M. Multidrug-resistant community-acquired urinary tract infections in a northern region of Morocco: epidemiology and risk factors. Germs. 2021 Dec 29;11(4):562. https://doi.org/10.18683/germs.2021.1291

Lukac PJ, Bonomo RA, Logan LK. Extended-spectrum β-lactamase-producing Enterobacteriaceae in children: old foe, emerging threat. Clin Infect Dis. 2015 May 1;60(9):1389-97. https://doi.org/10.1093/cid/civ020.

Strysko JP, Mony V, Cleveland J, Siddiqui H, Homel P, Gagliardo C. International travel is a risk factor for extended-spectrum β-lactamase-producing Enterobacteriaceae acquisition in children: a case-case-control study in an urban US hospital. Travel medicine and infectious disease. 2016 Nov 1;14(6):568-71 https://doi.org/10.1016/j.tmaid.2016.11.012

Downloads

Published

2025-03-31

How to Cite

Abbasi, M., Aziz, K. T., & Abbasi, A. (2025). Incidence of Multidrug-Resistant UTI. Indus Journal of Bioscience Research, 3(3), 631-636. https://doi.org/10.70749/ijbr.v3i3.950